{"id":"https://openalex.org/W7129007108","doi":"https://doi.org/10.1001/jamaneurol.2026.0007","title":"Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study","display_name":"Five Years of Ublituximab in Multiple Sclerosis: ULTIMATE I and II Open-Label Extension Study","publication_year":2026,"publication_date":"2026-02-16","ids":{"openalex":"https://openalex.org/W7129007108","doi":"https://doi.org/10.1001/jamaneurol.2026.0007","pmid":"https://pubmed.ncbi.nlm.nih.gov/41697690","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12910456"},"language":"en","primary_location":{"id":"doi:10.1001/jamaneurol.2026.0007","doi":"https://doi.org/10.1001/jamaneurol.2026.0007","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2026.0007","pdf_url":null,"source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1001/jamaneurol.2026.0007","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020903163","display_name":"Bruce Cree","orcid":"https://orcid.org/0000-0001-7689-2533","observed_orcids":["https://orcid.org/0000-0001-7689-2533"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bruce A. C. Cree","raw_affiliation_strings":["Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Edward Fox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward Fox","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110362167","display_name":"Hans-Peter Hartung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I44260953","display_name":"Heinrich Heine University D\u00fcsseldorf","ror":"https://ror.org/024z2rq82","country_code":"DE","type":"education","lineage":["https://openalex.org/I44260953"]},{"id":"https://openalex.org/I70703428","display_name":"Palack\u00fd University Olomouc","ror":"https://ror.org/04qxnmv42","country_code":"CZ","type":"education","lineage":["https://openalex.org/I70703428"]}],"countries":["AU","CZ","DE"],"is_corresponding":false,"raw_author_name":"Hans-Peter Hartung","raw_affiliation_strings":["Brain and Mind Centre, University of Sydney, Sydney New South Wales, Australia","Department of Neurology, Palack\u00fd University Olomouc, Olomouc, Czech Republic","Heinrich Heine University Medical School, D\u00fcsseldorf, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brain and Mind Centre, University of Sydney, Sydney New South Wales, Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Department of Neurology, Palack\u00fd University Olomouc, Olomouc, Czech Republic","institution_ids":["https://openalex.org/I70703428"]},{"raw_affiliation_string":"Heinrich Heine University Medical School, D\u00fcsseldorf, Germany","institution_ids":["https://openalex.org/I44260953"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064205043","display_name":"Enrique \u00c1lvarez","orcid":"https://orcid.org/0000-0001-5854-9643","observed_orcids":["https://orcid.org/0000-0001-5854-9643","https://orcid.org/0000-0001-8344-9791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enrique Alvarez","raw_affiliation_strings":["University of Colorado, Aurora"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado, Aurora","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087362850","display_name":"Peiqing Qian","orcid":"https://orcid.org/0000-0003-4774-7788","observed_orcids":["https://orcid.org/0000-0003-4774-7788"]},"institutions":[{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peiqing Qian","raw_affiliation_strings":["Swedish Medical Center, Seattle, Washington"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Medical Center, Seattle, Washington","institution_ids":["https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112090905","display_name":"Sibyl E. Wray","orcid":"https://orcid.org/0000-0001-5116-8776","observed_orcids":["https://orcid.org/0000-0001-5116-8776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sibyl Wray","raw_affiliation_strings":["Hope Neurology, Knoxville, Tennessee"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hope Neurology, Knoxville, Tennessee","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049160943","display_name":"Derrick S. Robertson","orcid":"https://orcid.org/0000-0001-8993-0981","observed_orcids":["https://orcid.org/0000-0001-8993-0981"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Derrick Robertson","raw_affiliation_strings":["University of South Florida, Tampa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of South Florida, Tampa","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140357783","display_name":"Krzysztof Selmaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47996466","display_name":"University of Warmia and Mazury in Olsztyn","ror":"https://ror.org/05s4feg49","country_code":"PL","type":"education","lineage":["https://openalex.org/I47996466"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Krzysztof Selmaj","raw_affiliation_strings":["Department of Neurology, University of Warmia and Mazury, Olsztyn, and Center of Neurology, Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Warmia and Mazury, Olsztyn, and Center of Neurology, Lodz, Poland","institution_ids":["https://openalex.org/I47996466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065830564","display_name":"Daniel R. Wynn","orcid":"https://orcid.org/0000-0002-7214-8552","observed_orcids":["https://orcid.org/0000-0002-7214-8552"]},"institutions":[{"id":"https://openalex.org/I4210124330","display_name":"Consultants in Neurology","ror":"https://ror.org/024f1d020","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210124330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Wynn","raw_affiliation_strings":["Consultants in Neurology, Northbrook, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultants in Neurology, Northbrook, Illinois","institution_ids":["https://openalex.org/I4210124330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083797307","display_name":"Koby Mok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koby Mok","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078925187","display_name":"Christopher R. Rowland","orcid":"https://orcid.org/0000-0003-0228-4054","observed_orcids":["https://orcid.org/0000-0003-0228-4054"]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Rowland","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068409108","display_name":"Karthik Bodhinathan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karthik Bodhinathan","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074058246","display_name":"Peter Sportelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Sportelli","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007928824","display_name":"Hari P. Miskin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405266996","display_name":"TG Therapeutics, Inc. (United States)","ror":"https://ror.org/00pwykz63","country_code":"US","type":"company","lineage":["https://openalex.org/I4405266996"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hari P. Miskin","raw_affiliation_strings":["TG Therapeutics, Morrisville, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TG Therapeutics, Morrisville, North Carolina","institution_ids":["https://openalex.org/I4405266996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066671501","display_name":"Lawrence Steinman","orcid":"https://orcid.org/0000-0002-2437-2250","observed_orcids":["https://orcid.org/0000-0002-2437-2250"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Steinman","raw_affiliation_strings":["Beckman Center for Molecular Medicine, Stanford University, Stanford, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beckman Center for Molecular Medicine, Stanford University, Stanford, California","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5020903163"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":30.4443,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.99760843,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"83","issue":"4","first_page":"348","last_page":"348"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ublituximab","display_name":"ublituximab","score":1.0},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/teriflunomide","display_name":"teriflunomide","score":0.8389999866485596},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.609000027179718},{"id":"https://openalex.org/keywords/annualized-relapse-rate","display_name":"annualized relapse rate","score":0.8130000233650208},{"id":"https://openalex.org/keywords/confirmed-disability-progression","display_name":"confirmed disability progression","score":0.8389999866485596},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.699999988079071},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6340000033378601},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.44699999690055847},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5099999904632568},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.5600000023841858},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.47200000286102295},{"id":"https://openalex.org/keywords/hepatitis-b","display_name":"hepatitis B","score":0.31200000643730164},{"id":"https://openalex.org/keywords/hepatitis-c","display_name":"hepatitis C","score":0.4729999899864197},{"id":"https://openalex.org/keywords/cytomegalovirus","display_name":"cytomegalovirus","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2777703276","wikidata":"https://www.wikidata.org/wiki/Q3077133","display_name":"Teriflunomide","level":4,"score":0.8568999767303467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8388000130653381},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8259000182151794},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.5236999988555908},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47679999470710754},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42010000348091125},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.40849998593330383},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39969998598098755},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.39890000224113464},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3946000039577484},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3675999939441681},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31060001254081726},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.30640000104904175},{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.29249998927116394},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.26579999923706055},{"id":"https://openalex.org/C2779281540","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Central nervous system disease","level":2,"score":0.25110000371932983}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003437","descriptor_name":"Crotonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006885","descriptor_name":"Hydroxybutyrates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014052","descriptor_name":"Toluidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamaneurol.2026.0007","doi":"https://doi.org/10.1001/jamaneurol.2026.0007","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2026.0007","pdf_url":null,"source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},{"id":"pmid:41697690","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41697690","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA neurology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12910456","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12910456/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1001/jamaneurol.2026.0007","doi":"https://doi.org/10.1001/jamaneurol.2026.0007","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2026.0007","pdf_url":null,"source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W2061374640","https://openalex.org/W2087671528","https://openalex.org/W2093394631","https://openalex.org/W2109939012","https://openalex.org/W2119408292","https://openalex.org/W2126336004","https://openalex.org/W2150378783","https://openalex.org/W2774037113","https://openalex.org/W2795482501","https://openalex.org/W2977883158","https://openalex.org/W3012517977","https://openalex.org/W3022913130","https://openalex.org/W3041766698","https://openalex.org/W3045030255","https://openalex.org/W3195209506","https://openalex.org/W3198774415","https://openalex.org/W4281612308","https://openalex.org/W4293105031","https://openalex.org/W4315709064","https://openalex.org/W4323253165","https://openalex.org/W4360619161","https://openalex.org/W4386592575","https://openalex.org/W4386845413","https://openalex.org/W4387446354","https://openalex.org/W4387729405","https://openalex.org/W4394791063","https://openalex.org/W4403761889","https://openalex.org/W4407326236","https://openalex.org/W4409181930","https://openalex.org/W4412370560"],"related_works":["https://openalex.org/W4409226466","https://openalex.org/W4293105031","https://openalex.org/W4389376801","https://openalex.org/W4283455968","https://openalex.org/W4367303018","https://openalex.org/W4367304217","https://openalex.org/W4389460561","https://openalex.org/W4307853671","https://openalex.org/W4312726650","https://openalex.org/W4403729756"],"abstract_inverted_index":{"Importance:":[0],"In":[1],"the":[2,7,66,82,155,162,181,210,233,267,317,349],"2-year":[3],"Study":[4],"to":[5,77,112,250,252],"Assess":[6],"Efficacy":[8,119],"and":[9,23,51,55,69,117,129,135,150,158,247,256,271,277,297,340,354,369,398,412],"Safety":[10],"of":[11,18,65,170,174,178,183,190,194,331,337,352,365,382,395,400,415],"Ublituximab":[12],"in":[13,37,81,154,161,286,291,301,306,358,386],"Participants":[14],"With":[15],"Relapsing":[16],"Forms":[17],"Multiple":[19],"Sclerosis":[20],"(ULTIMATE)":[21],"I":[22,68,149],"II":[24,70],"randomized":[25],"clinical":[26,49,375],"studies,":[27],"disease":[28],"activity":[29],"was":[30,97,284,299],"significantly":[31],"reduced":[32],"with":[33,39,144,316,324,379],"ublituximab":[34,48,106,113,198,383,396,410],"vs":[35,236,289,304],"teriflunomide":[36,111],"participants":[38,104,171,223,261,288,293,303,308,402],"relapsing":[40],"multiple":[41],"sclerosis":[42],"(RMS).":[43],"Objective:":[44],"To":[45],"evaluate":[46],"long-term":[47,409],"efficacy":[50],"safety.":[52],"Design,":[53],"Setting,":[54],"Participants:":[56],"The":[57],"2-year,":[58],"multicenter,":[59],"randomized,":[60],"active-controlled,":[61],"double-blind":[62],"period":[63],"(DBP)":[64],"ULTIMATE":[67,84,102,148,156],"phase":[71],"3":[72],"studies":[73],"occurred":[74],"September":[75],"2017":[76],"November":[78,90],"2020.":[79],"Enrollment":[80],"ongoing":[83],"open-label":[85],"extension":[86],"(OLE)":[87],"study":[88],"began":[89],"2019;":[91],"data":[92,206],"cutoff":[93],"for":[94,273],"this":[95],"analysis":[96,211],"January":[98],"1,":[99],"2024.":[100],"Intervention:":[101],"OLE":[103,157],"continued":[105,196,249],"(UBL-UBL)":[107,339],"or":[108],"switched":[109],"from":[110,321,405],"(TER-UBL).":[114,342],"Main":[115],"Outcomes":[116],"Measures:":[118],"(annualized":[120],"relapse":[121,391],"rate":[122,238],"[ARR],":[123],"24-week":[124,130],"confirmed":[125,131],"disability":[126,132],"progression":[127],"[CDP24],":[128],"improvement":[133],"[CDI24])":[134],"safety":[136,319],"were":[137,159,314,362,377],"key":[138],"outcomes.":[139],"Results:":[140],"Of":[141],"985":[142],"adults":[143],"RMS":[145],"who":[146],"completed":[147],"II,":[151],"851":[152],"enrolled":[153],"included":[160],"analysis.":[163],"On":[164,343],"DBP":[165,268],"completion,":[166],"more":[167,185],"than":[168,186],"85%":[169],"(UBL-UBL,":[172,188],"422":[173],"494;":[175],"TER-UBL,":[176,192],"429":[177],"491)":[179],"entered":[180],"OLE,":[182],"whom":[184],"70%":[187],"297":[189],"422;":[191],"327":[193],"429)":[195],"taking":[197],"at":[199,205,229],"year":[200,203,231,281,387],"5":[201,380,388],"(OLE":[202],"3)":[204],"cutoff,":[207],"making":[208],"up":[209],"population":[212],"(mean":[213],"[SD]":[214],"age,":[215],"38.5":[216],"[9.7]":[217],"years;":[218],"532":[219],"female":[220],"[62.5%]).":[221],"TER-UBL":[222,292,307],"experienced":[224],"a":[225],"58.4%":[226],"ARR":[227,248,264,385],"reduction":[228],"1":[230,390],"after":[232,266],"switch":[234],"(0.182":[235],"0.076;":[237],"ratio,":[239],"0.42;":[240],"95%":[241],"CI,":[242],"0.29-0.60;":[243],"P":[244],"<":[245],".001),":[246],"decrease":[251],"0.048":[253],"(year":[254,258],"4)":[255],"0.045":[257],"5).":[259],"UBL-UBL":[260,287,302,401],"had":[262],"further":[263],"reductions":[265],"(0.053,":[269],"0.032,":[270],"0.020":[272],"years":[274,381],"3,":[275],"4,":[276],"5,":[278,282],"respectively).":[279],"At":[280],"CDP24":[283],"8.0%":[285],"14.3%":[290],"(P":[294,309],"=":[295,310],".01),":[296],"CDI24":[298],"17.0%":[300],"12.2%":[305],".02).":[311],"Adverse":[312],"events":[313],"consistent":[315],"established":[318],"profile":[320],"pivotal":[322],"trials,":[323],"exposure-adjusted":[325],"incidence":[326],"rates":[327,361],"per":[328,392],"100":[329],"participant-years":[330,394],"serious":[332,359],"infections":[333],"(excluding":[334],"COVID":[335],"events)":[336],"2.10":[338],"2.58":[341],"average,":[344],"immunoglobulin":[345,366],"levels":[346],"remained":[347,403],"above":[348],"lower":[350],"limit":[351],"normal,":[353],"no":[355],"significant":[356],"differences":[357],"infection":[360],"observed":[363,378],"regardless":[364],"level.":[367],"Conclusions":[368],"Relevance:":[370],"Results":[371,407],"reveal":[372],"that":[373],"sustained":[374],"benefits":[376,411],"treatment:":[384],"showed":[389],"50":[393],"treatment":[397],"92%":[399],"free":[404],"CDP24.":[406],"confirm":[408],"early":[413],"initiation":[414],"high-efficacy":[416],"treatment.":[417],"Trial":[418],"Registration:":[419],"ClinicalTrials.gov":[420],"Identifier:":[421],"NCT04130997.":[422]},"counts_by_year":[{"year":2026,"cited_by_count":10}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-02-17T00:00:00"}